Walter, J.; Mende, J.; Hutagalung, S.; Alhalabi, O.T.; Grutza, M.; Zheng, G.; Skutella, T.; Unterberg, A.; Zweckberger, K.; Younsi, A.
The Single-Dose Application of Interleukin-4 Ameliorates Secondary Brain Damage in the Early Phase after Moderate Experimental Traumatic Brain Injury in Mice. Int. J. Mol. Sci. 2023, 24, 12756.
https://doi.org/10.3390/ijms241612756
AMA Style
Walter J, Mende J, Hutagalung S, Alhalabi OT, Grutza M, Zheng G, Skutella T, Unterberg A, Zweckberger K, Younsi A.
The Single-Dose Application of Interleukin-4 Ameliorates Secondary Brain Damage in the Early Phase after Moderate Experimental Traumatic Brain Injury in Mice. International Journal of Molecular Sciences. 2023; 24(16):12756.
https://doi.org/10.3390/ijms241612756
Chicago/Turabian Style
Walter, Johannes, Jannis Mende, Samuel Hutagalung, Obada T. Alhalabi, Martin Grutza, Guoli Zheng, Thomas Skutella, Andreas Unterberg, Klaus Zweckberger, and Alexander Younsi.
2023. "The Single-Dose Application of Interleukin-4 Ameliorates Secondary Brain Damage in the Early Phase after Moderate Experimental Traumatic Brain Injury in Mice" International Journal of Molecular Sciences 24, no. 16: 12756.
https://doi.org/10.3390/ijms241612756
APA Style
Walter, J., Mende, J., Hutagalung, S., Alhalabi, O. T., Grutza, M., Zheng, G., Skutella, T., Unterberg, A., Zweckberger, K., & Younsi, A.
(2023). The Single-Dose Application of Interleukin-4 Ameliorates Secondary Brain Damage in the Early Phase after Moderate Experimental Traumatic Brain Injury in Mice. International Journal of Molecular Sciences, 24(16), 12756.
https://doi.org/10.3390/ijms241612756
